Posted by Phillipa on August 24, 2007, at 10:15:46
In reply to bioequivalence of generics not always same, posted by sam123 on August 24, 2007, at 9:27:24
Thought they had to be within 20% of original formulation . Of course this doesn't account for different fillers, dyes. I know synthroid is going generic end of year but the endos say it will not differ by more than 5%. So there are not formal studies? Could this account for TRD? And other disorders. Frightening about the dilantin. Thanks. Phillipa
poster:Phillipa
thread:778283
URL: http://www.dr-bob.org/babble/20070824/msgs/778292.html